Business

CareDx Agrees to Acquire TransChart and Expands EMR Connectivity to Over 90 Centers

Acquisition will build on CareDx’s digital capabilities and continue deepening the moat with transplant centers SOUTH SAN FRANCISCO, Calif., Jan. 08, 2021

articleCaredx, Inc.January 8, 20214/company/caredx-inc/news/caredx-agrees-to-acquire-transchart-and-expands-emr-connectivity-to-over-90-centers
CareDx Agrees to Acquire TransChart and Expands EMR Connectivity to Over 90 Centers

About this update from Caredx, Inc.

[{"type":"text","content":"Acquisition will build on CareDx’s digital capabilities and continue deepening the moat with transplant centers\nSOUTH SAN FRANCISCO, Calif., Jan. 08, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced it has agreed to acquire TransChart LLC, an Ohio-based provider of electronic health record software supporting the needs of US transplant centers. The transaction is expected to close in January 2021. TransChart provides electronic medical record software to hospitals throughout the United States to care for patients who have or may need an organ transplant. TransChart builds on the CareDx digital offerings, which include Ottr transplant electronic medical record software and XynQAPI transplant quality management solutions. This acquisition will expand CareDx’s EMR coverage to over 90 centers in total. “CareDx and TransChart are aligned in our dedication to improve outcomes for transplant patients through data-driven solutions,” said Reg Seeto, CEO of CareDx. “The addition of TransChart into our existing suite of transplant electronic medical record solutions will allow CareDx to better serve additional transplant centers.” “CareDx is a perfect fit for our organization. Together we will make a major difference, not only in individual centers but to individual transplant patients,” said Martha Collins, President of TransChart. About CareDxCareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. For more information, please visit: www.CareDx.com. About TransChartTransChart headquartered in Columbus, Ohio, supports the needs of transplant centers across the country. TransChart offers support for the transplant of kidney, heart, lung, liver, pancreas (Islet Cell), and small bowel. Designed by clinicians affiliated with The Ohio State University, TransChart’s solutions support the entire team of physicians, nurses, administrators and social workers. Forward Looking StatementsThis press release includes fo...

More updates from Caredx, Inc.